<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9888476</article-id><article-id pub-id-type="pmc">2362202</article-id><article-id pub-id-type="pii">6690052</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690052</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>G D</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Paschoud</surname><given-names>N</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pavy</surname><given-names>J-J</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Weber</surname><given-names>K</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Weber</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dubray</surname><given-names>B</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Coucke</surname><given-names>P A</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, UK</aff><aff id="aff2"><label>2</label>Laboratoire de Cytom&#x000e9;trie en Flux, Clinique La Source, Lausanne, Switzerland</aff><aff id="aff3"><label>3</label>Department of Radiotherapy, Centre Hospitalier Universitaire, Besan&#x000e7;on, France</aff><aff id="aff4"><label>4</label>Oncologie Radiotherapeutique, Institut Curie, 26 Rue d'Ulm, Paris, 75248, France</aff><aff id="aff5"><label>5</label>Department of Radiotherapy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland</aff><pub-date pub-type="ppub"><month>01</month><year>1999</year></pub-date><volume>79</volume><issue>2</issue><fpage>323</fpage><lpage>332</lpage><history><date date-type="received"><day>05</day><month>03</month><year>1998</year></date><date date-type="rev-recd"><day>14</day><month>05</month><year>1998</year></date><date date-type="accepted"><day>07</day><month>06</month><year>1998</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><abstract><p>We compared the flow cytometric measurement and analysis of the potential doubling time (<italic>T</italic><sub>pot</sub>) between three centres involved in the National Cancer Institute (NCI) protocol T92-0045. The primary purpose was to understand and minimize the variation within the measurement. A total of 102 specimens were selected at random from patients entered into the trial. Samples were prepared, stained, run and analysed in each centre and a single set of data analysed by all three centres. Analysis of the disc data set revealed that the measurement of labelling index (LI) was robust and reproducible. The estimation of duration of S-phase (<italic>T</italic><sub>s</sub>) was subject to errors of profile interpretation, particularly DNA ploidy status, and analysis. The LI dominated the variation in <italic>T</italic><sub>pot</sub> such that the level of final agreement, after removal of outliers and ploidy agreement, reached correlation coefficients of 0.9. The sample data showed poor agreement within each of the components of the measurement. There was some improvement when ploidy was in agreement, but correlation coefficients failed to exceed values of 0.5 for <italic>T</italic><sub>pot</sub>. The data suggest that observer-associated analysis of <italic>T</italic><sub>s</sub> and tissue processing and tumour heterogeneity were the major causes of variability in the <italic>T</italic><sub>pot</sub> measurement. The first two aspects can be standardized and minimized, but heterogeneity will remain a problem with biopsy techniques. &#x000a9; 1999 Cancer Research Campaign</p></abstract><kwd-group><kwd>proliferation</kwd><kwd>reproducibility</kwd><kwd>conventional radiotherapy</kwd><kwd>multicentre</kwd><kwd>flow cytometry</kwd></kwd-group></article-meta></front></article>


